OPKO Health, Inc.

NASDAQ:OPK

Biotechnology

Healthcare
$1.69 +0.52%

+$0.01 today

Market cap
$1.25B
Beta
1.49
P/E (TTM)
-5.1
EPS (TTM)
-$0.28
52W Low $0.98High $1.60

Volume 3.06M

Average 2.59M

OPK Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

OPKO Health, Inc.NASDAQ: OPK

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares growth accelerates

Q1 FY2026 weighted avg shares of 758.88M shares rose 13.0% year over year, ahead of the +8.0% change in trailing-twelve-month weighted avg shares. Sequentially, it fell 0.9% from the prior quarter. Over 3 fiscal years it compounded at +1.5% a year.

Context

  • Weighted avg shares increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +13.0% holds above the trailing-twelve-month pace of +8.0%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
758.88M-0.9% QoQ
Last fiscal yearDec 2025
751.13M+8.2% YoY
LTMMar 2026
772.39M+8.0% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+13.0%——
1 year+8.2%——
3-year CAGR+1.5%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
751.13M USD
Year-over-year change
+8.2%
4-year CAGR
+3.8%

Weighted Avg Shares vs competitors

How OPK compares with its peers on the latest reported figures

  • OPK's LTM Mar 2026 weighted avg shares of 772.39M shares is the highest of the 11 companies compared; the peer median is 71.59M shares.
  • Its year-over-year change of +8.0% is the 3rd highest of 11, against a peer median of +2.6%.
  • Over three fiscal years its annual growth of +1.5% compares with a peer median of +7.1%.
OPK Competitors Peer median
Weighted Avg Shares for OPK and competitors
Company Period LTM YoY 3-year CAGR
OPKOPKO Health, Inc.LTM Mar 2026772.39M +8.0%+1.5%
NTRANatera, Inc.LTM Jun 2026139.67M +7.5%+11.6%
GHGuardant Health, Inc.LTM Sep 2026131.61M +6.0%+7.1%
NEONeoGenomics, Inc.LTM Jun 2026128.84M +1.3%+1.0%
PSNLPersonalis, Inc.LTM Mar 202693.42M +36.5%+25.0%
MYGNMyriad Genetics, Inc.LTM Mar 202693.15M +2.4%+5.0%
MDXHMDxHealth S.A.FY202550.03M +2.8%+46.6%
BLLNBillionToOne, Inc.LTM Jun 202645.72M +2.2%—
FLGTFulgent Genetics, Inc.LTM Mar 202630.81M +1.0%+0.7%
CSTLCastle Biosciences, Inc.LTM Mar 202628.3M +0.9%+3.6%
XGNExagen Inc.LTM Mar 202622.34M +22.1%+8.1%
Peer median (excluding OPK) 71.59M+2.6%+7.1%

Competitors are the stored peer set for OPK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.77B1B863.5M713.14M606.88M
Cost of Revenue1.19B715.98M545.37M402.11M478.83M
Gross Profit581.52M288.22M318.13M311.03M128.05M
Gross Margin32.8%28.7%36.8%43.6%21.1%
Research & Development76.85M73.89M89.59M105.21M124.03M
Selling, General & Admin468.86M372.67M300.56M304.22M223M
Operating Expenses562.77M514.47M475.15M463.1M347.04M
Depreciation & Amortization78.72M108.66M105.3M98.18M91.63M
EBITDA83.57M(270.81M)(65.52M)135.28M(41.3M)
EBITDA Margin4.7%-27.0%-7.6%19.0%-6.8%
Operating Income18.75M(226.25M)(157.02M)(152.07M)(218.99M)
Operating Margin1.1%-22.5%-18.2%-21.3%-36.1%
Interest Income28K1.98M3.98M8.43M14.81M
Interest Expense18.88M12.06M13.51M47.47M108.46M
Other Income / Expenses(33.4M)(165.65M)(27.41M)141.7M(22.41M)
Income Before Tax(14.65M)(391.9M)(184.43M)(10.36M)(241.39M)
Pre-Tax Margin-0.8%-39.0%-21.4%-1.5%-39.8%
Income Tax Expense15.49M(63.5M)4.44M42.84M(15.71M)
Net Income(30.14M)(328.41M)(188.86M)(53.22M)(225.68M)
Net Margin-1.7%-32.7%-21.9%-7.5%-37.2%
EPS (Basic)(0.05)(0.46)(0.25)(0.08)(0.30)
EPS (Diluted)(0.05)(0.46)(0.25)(0.08)(0.30)
Weighted Avg Shares648.08M719.06M751.77M694.02M751.13M
Weighted Avg Shares (Diluted)648.08M719.06M751.77M694.02M751.13M

OPKO Health, Inc.

NASDAQ:OPK

Intrinsic Alpha fair value

Locked

Current Price

$1.69

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.